Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Quantum-Si Incorporated (Nasdaq: QSI), The Protein Sequencing Company™, has announced that its Compensation Committee has granted a total of 385,983 restricted stock units (RSUs) to five new employees under the company's 2023 Inducement Equity Incentive Plan. These grants were made in accordance with Nasdaq Listing Rule 5635(c)(4) as inducements for the new employees joining Quantum-Si.
The RSUs will vest according to the following schedule: 25% on December 20, 2025, with the remaining 75% vesting in 12 equal quarterly installments thereafter. Vesting is subject to the employees' continued employment with Quantum-Si. The RSUs are governed by the terms and conditions of the 2023 Inducement Plan and the respective RSU agreements.
Quantum-Si Incorporated (Nasdaq: QSI), La Società di Sequenziamento delle Proteine™, ha annunciato che il suo Comitato per la Compensazione ha concesso un totale di 385,983 unità di azioni vincolate (RSU) a cinque nuovi dipendenti nell'ambito del Piano di Incentivo Azionario 2023 dell'azienda. Questi conferimenti sono stati effettuati in conformità con la Regola di Quotazione Nasdaq 5635(c)(4) come incentivo per i nuovi dipendenti che si uniscono a Quantum-Si.
Le RSU matureranno secondo il seguente piano: 25% il 20 dicembre 2025, con il restante 75% che maturerà in 12 rate trimestrali uguali successivamente. La maturazione è soggetta al mantenimento dell'impiego dei dipendenti con Quantum-Si. Le RSU sono regolate dai termini e dalle condizioni del Piano di Incentivo 2023 e dai rispettivi accordi RSU.
Quantum-Si Incorporated (Nasdaq: QSI), La Compañía de Secuenciación de Proteínas™, ha anunciado que su Comité de Compensación ha otorgado un total de 385,983 unidades de acciones restringidas (RSUs) a cinco nuevos empleados bajo el Plan de Incentivo de Capital de Inducción 2023 de la empresa. Estas concesiones se realizaron de acuerdo con la Regla de Cotización Nasdaq 5635(c)(4) como incentivos para los nuevos empleados que se unen a Quantum-Si.
Las RSUs se consolidarán según el siguiente cronograma: 25% el 20 de diciembre de 2025, con el 75% restante consolidándose en 12 cuotas trimestrales iguales a partir de entonces. La consolidación está sujeta a la continuidad del empleo de los empleados con Quantum-Si. Las RSUs están reguladas por los términos y condiciones del Plan de Inducción 2023 y los respectivos acuerdos de RSU.
Quantum-Si Incorporated (Nasdaq: QSI), 단백질 서열 분석 회사™,는 보상 위원회가 회사의 2023 유인 자본 인센티브 계획에 따라 다섯 명의 새 직원에게 총 385,983개의 제한 주식 단위(RSU)를 부여했다고 발표했습니다. 이러한 부여는 새로운 직원들이 Quantum-Si에 합류하는 데 대한 유인으로 Nasdaq 상장 규칙 5635(c)(4)에 따라 이루어졌습니다.
RSU는 다음 일정에 따라 발생합니다: 2025년 12월 20일까지 25%, 이후에는 나머지 75%가 12회 분기별 동등 할부로 발생합니다. 발생은 직원들이 Quantum-Si에 계속 근무하는 것에 따라 달라집니다. RSU는 2023 유인 계획의 조건 및 해당 RSU 계약에 따라 규율됩니다.
Quantum-Si Incorporated (Nasdaq: QSI), La Société de Séquençage de Protéines™, a annoncé que son Comité de Rémunération a accordé un total de 385,983 unités d'actions restreintes (RSUs) à cinq nouveaux employés dans le cadre du Plan d'Incentive d'Equité d'Induction 2023 de l'entreprise. Ces attributions ont été faites conformément à la Règle de Cotation Nasdaq 5635(c)(4) en tant qu'incitations pour les nouveaux employés rejoignant Quantum-Si.
Les RSUs seront acquises selon le calendrier suivant : 25 % le 20 décembre 2025, le reste de 75 % étant acquis en 12 versements trimestriels égaux par la suite. L'acquisition est soumise à la poursuite de l'emploi des employés avec Quantum-Si. Les RSUs sont régis par les termes et conditions du Plan d'Incentive de 2023 et les accords RSU respectifs.
Quantum-Si Incorporated (Nasdaq: QSI), Das Protein-Sequenzierungsunternehmen™, hat bekannt gegeben, dass sein Vergütungsausschuss insgesamt 385,983 eingeschränkte Aktieneinheiten (RSUs) an fünf neue Mitarbeiter im Rahmen des Unternehmens 2023 Incentive-Eigenkapitalplans vergeben hat. Diese Zuwendungen erfolgten gemäß Nasdaq-Listing-Regel 5635(c)(4) als Anreize für die neuen Mitarbeiter, die zu Quantum-Si stoßen.
Die RSUs werden nach folgendem Zeitplan fällig: 25% am 20. Dezember 2025, wobei die verbleibenden 75% in 12 gleichmäßigen vierteljährlichen Raten anschließend fällig wird. Die Fälligkeit unterliegt der Fortsetzung der Anstellung der Mitarbeiter bei Quantum-Si. Die RSUs unterliegen den Bedingungen und Konditionen des Incentive-Plans 2023 und den jeweiligen RSU-Vereinbarungen.
- Quantum-Si is attracting new talent with equity incentives
- The company has a structured vesting schedule for RSUs, promoting employee retention
- The RSU grants may lead to potential shareholder dilution
The 2023 Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously employees of Quantum-Si (or following a bona fide period of non-employment), as an inducement material to such individuals’ entering into employment with Quantum-Si, pursuant to Rule 5635(c)(4) of the Nasdaq Listing Rules.
The RSUs will vest as to
About Quantum-Si Incorporated
Quantum-Si, The Protein Sequencing Company™, is focused on revolutionizing the growing field of proteomics. The Company’s Platinum® instrument enables Next-Generation Protein Sequencing™ that advances proteomic research, drug discovery, and diagnostics beyond what has been possible with existing proteomic tools. Learn more at quantum-si.com or follow us on LinkedIn or X.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241017336428/en/
Investor Contact
Doug Farrell, VP, Investor Relations
ir@quantum-si.com
Media Contact
Katherine Atkinson, SVP, Commercial Marketing
media@quantum-si.com
Source: Quantum-Si Incorporated
FAQ
How many restricted stock units (RSUs) did Quantum-Si (QSI) grant to new employees?
What is the vesting schedule for the RSUs granted by Quantum-Si (QSI)?
Under which plan were the RSUs granted by Quantum-Si (QSI)?
What is the purpose of Quantum-Si's (QSI) 2023 Inducement Plan?
